organization · Reporting owner
GV 2014 GP, L.L.C.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Oscar Health, Inc.OSCR · Entity 3582 | 10% owner | August 17, 2023 | August 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Oscar Health, Inc.
Report date August 17, 2023 · Filed August 21, 2023
Jointly reported with Alphabet Inc., Alphabet Holdings LLC, CapitalG 2015 LP, CapitalG 2015 GP LLC, CapitalG LP, CapitalG GP LLC, GV 2014, L.P., Verily Life Sciences LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 15,625,310 |
Reported balance
After 2023-08-17 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2023-08-17 · Sale · Disposed 5,719,438 · Balance 15,625,310 F1: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F2: These shares are owned directly by Alphabet Holdings LLC. XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,180,474 |
Reported balance
After 2023-08-17 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2023-08-17 · Sale · Disposed 525,470 · Balance 1,180,474 F1: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F3: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2023-08-17 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2023-08-17 · Sale · Disposed 255,092 · Balance 0 F1: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F4: These shares are owned directly by Verily Life Sciences LLC. OB Technology Holdings Inc., the managing member of Verily Life Sciences LLC, XXVI Holdings Inc., the managing member of OB Technology Holdings Inc., and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of OB Technology Holdings Inc., XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 255,092 |
Reported balance
Holding disclosure · report date 2023-08-17 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 255,092 F5: These shares are owned directly by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 481,988 |
Reported balance
Holding disclosure · report date 2023-08-17 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 481,988 F6: These shares are owned directly by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the managing member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period.
F2: These shares are owned directly by Alphabet Holdings LLC. XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F3: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F4: These shares are owned directly by Verily Life Sciences LLC. OB Technology Holdings Inc., the managing member of Verily Life Sciences LLC, XXVI Holdings Inc., the managing member of OB Technology Holdings Inc., and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of OB Technology Holdings Inc., XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F5: These shares are owned directly by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
F6: These shares are owned directly by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the managing member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARMO BioSciences, Inc.
Report date January 30, 2018 · Filed January 30, 2018
Jointly reported with GV 2014, L.P., Alphabet Inc.
Section 16 reporting ended · disclosed 2018-01-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy GV 2014, L.P. | 607,350 |
Reported balance
After 2018-01-30 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-01-30 · Conversion · Acquired 607,350 · Balance 607,350 F1: The total represents shares received upon conversion of shares of Series C Convertible Preferred Stock. F3: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F2: The reported security is directly held by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the sole member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
| Series C Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectBy GV 2014, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-01-30 · Conversion · Disposed 607,350 · Balance 0 F3: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F2: The reported security is directly held by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the sole member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The total represents shares received upon conversion of shares of Series C Convertible Preferred Stock.
F2: The reported security is directly held by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the sole member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
F3: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2023 Filed Aug 21, 2023 16:30 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 255,092 | $8.08 | $2,061,398.45 |
DisclosureSEC source: 0000929638-23-002316 · form4.xml · nonDerivative · entry 3 Alphabet Inc. · CIK 0001652044 · 10% owner Alphabet Holdings LLC · CIK 0001847337 · 10% owner CapitalG 2015 LP · CIK 0001771167 · 10% owner CapitalG 2015 GP LLC · CIK 0001779431 · 10% owner CapitalG LP · CIK 0001678225 · 10% owner CapitalG GP LLC · CIK 0001678226 · 10% owner GV 2014 GP, L.L.C. · CIK 0001728736 · 10% owner GV 2014, L.P. · CIK 0001728797 · 10% owner Verily Life Sciences LLC · CIK 0001848282 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · price: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F4 · ownership.nature: These shares are owned directly by Verily Life Sciences LLC. OB Technology Holdings Inc., the managing member of Verily Life Sciences LLC, XXVI Holdings Inc., the managing member of OB Technology Holdings Inc., and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of OB Technology Holdings Inc., XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 16:30 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 525,470 | $8.08 | $4,246,323.07 |
DisclosureSEC source: 0000929638-23-002316 · form4.xml · nonDerivative · entry 2 Alphabet Inc. · CIK 0001652044 · 10% owner Alphabet Holdings LLC · CIK 0001847337 · 10% owner CapitalG 2015 LP · CIK 0001771167 · 10% owner CapitalG 2015 GP LLC · CIK 0001779431 · 10% owner CapitalG LP · CIK 0001678225 · 10% owner CapitalG GP LLC · CIK 0001678226 · 10% owner GV 2014 GP, L.L.C. · CIK 0001728736 · 10% owner GV 2014, L.P. · CIK 0001728797 · 10% owner Verily Life Sciences LLC · CIK 0001848282 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,180,474 F1 · price: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F3 · ownership.nature: These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 16:30 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 5,719,438 | $8.08 | $46,218,778.48 |
DisclosureSEC source: 0000929638-23-002316 · form4.xml · nonDerivative · entry 1 Alphabet Inc. · CIK 0001652044 · 10% owner Alphabet Holdings LLC · CIK 0001847337 · 10% owner CapitalG 2015 LP · CIK 0001771167 · 10% owner CapitalG 2015 GP LLC · CIK 0001779431 · 10% owner CapitalG LP · CIK 0001678225 · 10% owner CapitalG GP LLC · CIK 0001678226 · 10% owner GV 2014 GP, L.L.C. · CIK 0001728736 · 10% owner GV 2014, L.P. · CIK 0001728797 · 10% owner Verily Life Sciences LLC · CIK 0001848282 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 15,625,310 F1 · price: On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period. F2 · ownership.nature: These shares are owned directly by Alphabet Holdings LLC. XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:09 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries C Convertible Preferred Stock · Derivative | 607,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-002282 · doc4.xml · derivative · entry 2 GV 2014 GP, L.L.C. · CIK 0001728736 · 10% owner GV 2014, L.P. · CIK 0001728797 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By GV 2014, L.P. Disclosed balance after: 0 Underlying: Common Stock · 607,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F3 · price: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F3 · derivative.exercise_date: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F3 · derivative.expiration_date: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F2 · ownership.nature: The reported security is directly held by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the sole member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:09 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 607,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-002282 · doc4.xml · nonDerivative · entry 1 GV 2014 GP, L.L.C. · CIK 0001728736 · 10% owner GV 2014, L.P. · CIK 0001728797 · 10% owner Alphabet Inc. · CIK 0001652044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By GV 2014, L.P. Disclosed balance after: 607,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The total represents shares received upon conversion of shares of Series C Convertible Preferred Stock. F3 · price: The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. F2 · ownership.nature: The reported security is directly held by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the sole member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.